Agios Pharmaceuticals Inc (AGIO)
29.64
+0.21
(+0.71%)
USD |
NASDAQ |
Apr 19, 12:50
Agios Pharmaceuticals Market Cap: 1.666B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 1.654B |
| April 17, 2024 | 1.631B |
| April 16, 2024 | 1.618B |
| April 15, 2024 | 1.644B |
| April 12, 2024 | 1.658B |
| April 11, 2024 | 1.721B |
| April 10, 2024 | 1.682B |
| April 09, 2024 | 1.670B |
| April 08, 2024 | 1.557B |
| April 05, 2024 | 1.548B |
| April 04, 2024 | 1.569B |
| April 03, 2024 | 1.600B |
| April 02, 2024 | 1.611B |
| April 01, 2024 | 1.622B |
| March 28, 2024 | 1.643B |
| March 27, 2024 | 1.636B |
| March 26, 2024 | 1.633B |
| March 25, 2024 | 1.668B |
| March 22, 2024 | 1.679B |
| March 21, 2024 | 1.699B |
| March 20, 2024 | 1.699B |
| March 19, 2024 | 1.691B |
| March 18, 2024 | 1.646B |
| March 15, 2024 | 1.682B |
| March 14, 2024 | 1.655B |
| Date | Value |
|---|---|
| March 13, 2024 | 1.686B |
| March 12, 2024 | 1.702B |
| March 11, 2024 | 1.731B |
| March 08, 2024 | 1.758B |
| March 07, 2024 | 1.763B |
| March 06, 2024 | 1.786B |
| March 05, 2024 | 1.763B |
| March 04, 2024 | 1.808B |
| March 01, 2024 | 1.813B |
| February 29, 2024 | 1.816B |
| February 28, 2024 | 1.892B |
| February 27, 2024 | 1.956B |
| February 26, 2024 | 1.847B |
| February 23, 2024 | 1.854B |
| February 22, 2024 | 1.673B |
| February 21, 2024 | 1.506B |
| February 20, 2024 | 1.523B |
| February 16, 2024 | 1.490B |
| February 15, 2024 | 1.506B |
| February 14, 2024 | 1.455B |
| February 13, 2024 | 1.413B |
| February 12, 2024 | 1.454B |
| February 09, 2024 | 1.413B |
| February 08, 2024 | 1.353B |
| February 07, 2024 | 1.325B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
934.70M
Minimum
Jun 14 2022
3.988B
Maximum
Feb 11 2021
2.237B
Average
1.998B
Median
Sep 26 2019
Market Cap Benchmarks
| Alnylam Pharmaceuticals Inc | 18.35B |
| Blueprint Medicines Corp | 5.309B |
| Corcept Therapeutics Inc | 2.351B |
| Ionis Pharmaceuticals Inc | 5.900B |
| Madrigal Pharmaceuticals Inc | 4.218B |
Market Cap Related Metrics
| PS Ratio | 61.49 |
| PEG Ratio | -0.0944 |
| Price to Book Value | 2.054 |
| Price | 29.64 |
| Earnings Yield | -21.39% |
| PEGY Ratio | -0.0944 |